3Tazuma S.Gallstone disease:epidemiology,pathogenesis,and classifi-cation of biliary stones(common bile duct and intrahepatic)[J].Best Pract Res Clin Gastroenterol,2006,20(6):1075-1083.
5Timo Vuorela,Andrea Catte,Perttu S et al.Role of Lipids in Spheroi-dal High Density Lipoproteins[J].PLoS Computational Biology,2010,6(10):e1000964.
6Ohta T,Nagakawa T,Takeda t,et al.Histological evaluation of the in-trahepatic biliary tree in intrahepatic cholesterol stones,including im-munohistochemical staining against apolipoprotein A-1[J].Hepa-tology,1993,17(4):531-537.
7Indumathi Chennamsetty,Thierry Claudel et al.Farnesoid X receptorrepresses hepatic human APOA gene expression[J].The Journal ofClinical Investigation,2011,121(9):3724-3734.
8Eriksson M,Sch?nland S,Yumlu S,et al.Hereditary apolipoproteinAI-associated amyloidosis in surgical pathology specimens:identifi-cation of three novel mutations in the APOA1 gene[J].The Journalof Molecular Diagnostics,2009,11(3):257-262.
10Ananthanarayanan M,Balasubramanian N,Makishima M,et al.Hu-man bile salt export pump promoter is transactivated by the far-ne-soid Xreceptor/bile acid receptor[J].J Biol Chem,2001,276(31):28857-28865.
10Maki T. Pathogenesis of calcium bilirubinate gallstones:role of E. coli, β- glucuronidase, and coagulation by inorganie ions, polyectorolytes and agitation[J]. Ann Surg,1966,164(1) :90-100.
